Swiss Dental Startup vVARDIS Begins Trading on NYSE Under VVVV
vVARDIS, a drill-free cavity treatment company, debuted on the New York Stock Exchange, marking a milestone for its co-founding Abivardi sisters.
Swiss dental health company vVARDIS began trading on the New York Stock Exchange under the ticker symbol VVVV on Nov. 13, 2026, marking the firm's entry into the U.S. public markets as it pushes a non-invasive approach to treating tooth decay.
The company was co-founded by Dr. Haley Abivardi and Dr. Goly Abivardi, who have positioned vVARDIS around a drill-free treatment targeting cavities — classified by health authorities as the world's most prevalent non-communicable disease, affecting hundreds of millions of people globally.
Read more Exchange Traded Concepts to Liquidate TSLA Income ETF TYYY →
The NYSE listing represents a significant capital-markets step for the startup, which is seeking to commercialize technology that challenges the traditional dental drill model that has defined cavity treatment for generations. The Abivardi co-founders framed the public offering as central to their broader ambition of reshaping preventive and restorative dental care at scale.
The dental technology sector has drawn growing investor interest in recent years as companies pursue alternatives to conventional clinical procedures. vVARDIS enters the public market with a differentiated pitch: addressing an enormous, underserved patient population through a treatment approach designed to reduce pain and procedural barriers associated with standard cavity care.
Continue reading at All Financial Services & Investing.